XTANT MEDICAL HOLDINGS, INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
XTANT MEDICAL HOLDINGS, INC. (XTNT) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $0 as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2018-05-08
- 2018-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2016-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |